Who will benefit from ACE inhibition?
Apr 23, 2013•11 min•Ep. 2
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Alistair Lindsay talks to Leong Ng about his work into using biomarkers to identify which groups of patients will benefit from ACE inhibition after acute coronary syndrome.
See also:
Identification of potential outcome benefit from ACE inhibition after acute coronary syndrome: a biomarker approach using N-terminal proBNP http://bit.ly/11hAfKc
For the best experience, listen in Metacast app for iOS or Android